Scinai Immunotherapeutics Ltd. (Stock Symbol: SCNI)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
a growing mid-cap opportunity with strong fundamentals.
Financial Performance & Key Metrics Analysis
Market Capitalization: $9674 million - Classified as a
mid-cap growth stock with balanced risk-reward profile.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Scinai Immunotherapeutics Ltd. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Scinai Immunotherapeutics Ltd. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share
.
Scinai Immunotherapeutics Ltd. (SCNI) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Scinai Immunotherapeutics Ltd. stock analysis.
Loading fundamental data...
Loading Scinai Immunotherapeutics Ltd. comprehensive fundamental analysis and insider trading data...
Deep dive into Scinai Immunotherapeutics Ltd.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Scinai Immunotherapeutics Ltd. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Scinai Immunotherapeutics Ltd.: With a P/E ratio of -287.75, the market sees the stock as potentially undervalued.
P/E Ratio-287.75x
P/B Ratio1231.15x
Market Cap$9674M
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Scinai Immunotherapeutics Ltd. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Scinai Immunotherapeutics Ltd.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Scinai Immunotherapeutics Ltd.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Scinai Immunotherapeutics Ltd.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Scinai Immunotherapeutics Ltd.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Scinai Immunotherapeutics Ltd.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Scinai Immunotherapeutics Ltd. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Scinai Immunotherapeutics Ltd.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Scinai Immunotherapeutics Ltd.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Q2 2024 Results Conference Call August 20, 2024 11:00 AM ETCompany ParticipantsLiat Halpert - Head of Business ...
JERUSALEM, Sept. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative biological ...
Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI” JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a ...
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I ...
--Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused both on development of inflammation and immunology biological therapeutic products and provision of boutique CDMO services ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing ...
Scinai Immunotherapeutics Ltd ADR SCNI Stock XNAS Rating as of Mar 14, 2025 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological ...
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I ...
Short interest in Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) decreased during the last reporting period, falling from 4.95K to 430.00. This put 0.15% of the company's publicly available shares ...
Comparative analysis of Scinai Immunotherapeutics Ltd. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
How accurate are Scinai Immunotherapeutics Ltd. stock predictions?
Our AI model demonstrates -22% historical accuracy for SCNI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Scinai Immunotherapeutics Ltd. stock price forecasts?
Is Scinai Immunotherapeutics Ltd. a good investment in 2025?
Based on our AI analysis, Scinai Immunotherapeutics Ltd. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Scinai Immunotherapeutics Ltd. forecasts updated?
Scinai Immunotherapeutics Ltd. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Scinai Immunotherapeutics Ltd. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Scinai Immunotherapeutics Ltd. stock.
